Kimberly Nackord
Acute Care · Walnut Creek, CANPI 1407305980
Payments from drug & device makers
Across 52 payments — averaging $20.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$197
- Pfizer$99
- GSK$96
- Novo Nordisk$96
- AstraZeneca$57
- Otsuka America Pharmaceutical, Inc.$54
- plus $461 from 15 others
What the payments were for
- Food & beverage$1,059100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 14 | $197 |
| Pfizer | 5 | $99 |
| GSK | 4 | $96 |
| Novo Nordisk | 4 | $96 |
| AstraZeneca | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Exact Sciences | 2 | $52 |
| Agios Pharmaceuticals, Inc. | 2 | $51 |
| Novartis | 2 | $45 |
| AbbVie | 2 | $43 |
| Johnson & Johnson | 2 | $35 |
| Sanofi-aventis U.S. LLC | 1 | $30 |
| Insmed, Inc. | 1 | $30 |
| Merck | 1 | $29 |
| Amgen | 1 | $26 |
| Dynavax Technologies Corporation | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Bayer | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $18 |
How this compares
$1,059 in reported general payments places this provider in the 75th percentile of 1,153 acute care providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 37 | $375 |
| Atorvastatin Calcium | 23 | $224 |
| Metformin Hcl | 14 | $220 |
| Gabapentin | 14 | $172 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $161 |
| Famotidine | 15 | $118 |
| Amlodipine Besylate | 16 | $86 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $86 |
| Lisinopril | 19 | $71 |
| Alendronate Sodium | 11 | $70 |
| Fluconazole | 11 | $55 |
| Lorazepam | 14 | $43 |
| Metformin Hcl ErMetformin Hcl | 11 | $19 |
Paid to pharmacies, not to this prescriber.
Other acute care in Walnut Creek
- Julia CeredaWalnut Creek$13K
- Leslie PetersenCamarillo$370K
- Joyce KhremianSan Dimas$73K
- Eleanor VierraSacramento$64K
- Frances DyLos Angeles$57K
- Savannah HarrisVentura$56K
- Kori Ann JohnstonLos Angeles$42K
- Caroline KwongOrange$42K
- Gregory KnutzenColton$41K
- Sunita BoparaiLos Angeles$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.